Answers are grounded in this paper and cite their sources.
Systematic review reveals comparable outcomes for SJS and TEN triggered by topical medications, suggesting clinician awareness is critical.
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are typically triggered by systemic medications but can also result from topical agents. In this systematic review of SJS/TEN cases caused by topical agents, the drug culprits, disease characteristics, and outcomes were comparable to systemic cases. Our findings highlight that topical formulations, though generally considered safer, can induce SJS and TEN, underscoring the need for clinician awareness, early recognition and accurate reporting.
No takes yet. Share an insight, caveat, or question.
Chee et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: